Junke Zheng

9PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 17, 2026
A multicohort, biomarker-driven phase 2 trial of personalized total neoadjuvant therapy with targeted agents for high-risk rectal cancer (The TRAINER study).

|Mar 04, 2026
Cell-free chromatin state tracing reveals disease origin and therapy responses.

Xubin Chen, Xiaoxuan Meng, Weilong Zhang

|Jan 16, 2026
PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells.

Keling Huang, Xiaoxue Li, Wenhua Liang

|May 26, 2025
The progression of multiple myeloma is regulated by LILRB1 via the GATA2-SAGE1 pathway.

Chiqi Chen, Xuanyi Zhou, Liyuan Cao

|Jul 18, 2024
LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway.

Li Xie, Chiqi Chen, Tinghua Zhang

|Jan 16, 2024
Integration of Pan-Cancer Single-Cell and Spatial Transcriptomics Reveals Stromal Cell Features and Therapeutic Targets in Tumor Microenvironment.

Yanhua Du, Jintong Shi, Jiaxin Wang

Pageof 2

Frequent Collaborators

3 joint publications

Youqiong Ye

2 joint publications

Chiqi Chen

2 joint publications

Ligen Liu

1 joint publications

Xiaoxin Hao